通过全身动态PET/CT确定前列腺癌中68Ga-PSMA PET/CT的最佳显像时间
该研究对11例前列腺癌患者行全身动态68Ga-PSMA PET/CT,分析病灶与膀胱的时间-放射性曲线。结果显示注射后6分钟病灶SUVmean最高但仍高于膀胱活性,而病灶SUVmean仅为60分钟时的三分之一至二分之一;注射后35分钟起病灶SUVmean与60分钟相似(均P>0.05)。结论为联合早期动态(75-360秒)与60分钟常规静态显像可避免膀胱干扰,也可在35-59分钟显像。
要点
- 注射后6分钟病灶SUVmean最高但仍高于膀胱活性,早期显像可能遗漏低PSMA摄取病灶。
- 注射后35分钟起病灶SUVmean与60分钟相似(均P>0.05),可在35-59分钟行68Ga-PSMA PET显像。
- 联合早期动态(75-360秒)与60分钟静态显像可避免膀胱活性干扰,更好检出病灶。
核心结论
- 联合早期动态68Ga-PSMA PET(75-360秒)与注射后60分钟常规静态显像可避免膀胱活性干扰,更好检出病理病灶和PSMA摄取相对较低的病灶。
- 注射后35-59分钟与60分钟的病灶SUVmean值相似,因此68Ga-PSMA PET也可在注射后35-59分钟进行显像。
研究设计与样本
- 对11例前列腺癌患者行全身动态68Ga-PSMA PET/CT,通过勾画正常器官和病理病灶(原发前列腺病灶、淋巴结和骨转移)的兴趣区获得时间-放射性曲线。
- 评估正常器官、膀胱和病理病灶的68Ga-PSMA摄取模式。
主要发现
- 膀胱时间-放射性曲线在注射后180至330秒缓慢上升,随后在注射后5.5至60.0分钟快速上升。
- 病理病灶摄取在注射后前5分钟快速上升,随后在剩余55分钟内缓慢上升。
- 注射后6分钟为最佳时间,此时病理病灶SUVmean值最高且仍高于膀胱活性值。
- 注射后6分钟时前列腺病灶、淋巴结转移和骨转移的SUVmean值分别为注射后60分钟对应值的三分之一、二分之一和二分之一,提示早期显像可能遗漏低PSMA摄取病灶。
- 病理病灶在注射后至少35分钟才达到与注射后60分钟相似的SUVmean值(均P>0.05),尽管病灶SUVmean值在60分钟内呈持续上升趋势。
临床怎么用
- 作者认为,联合早期动态68Ga-PSMA PET(75-360秒)与注射后60分钟常规静态显像可避免膀胱活性干扰,更好检出病理病灶和PSMA摄取相对较低的病灶。
- 作者指出,注射后35-59分钟与60分钟的病灶SUVmean值相似,因此68Ga-PSMA PET也可在注射后35-59分钟进行显像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 68 Ga-PSMA PET/CT has been widely used in patients with prostate cancer. Due to the limited axial field of view of conventional PET scanners, whole-body dynamic 68 Ga-PSMA PET/CT has not been performed. We investigated the time-activity curves (TACs) of prostate cancer pathological lesions and physiologic bladder activity to determine the optimal 68 Ga-PSMA PET/CT imaging time by total-body (TB) PET/CT. METHODS: Dynamic TB-PET performed on 11 patients with prostate cancer was analyzed. TACs were obtained by drawing regions of interest in normal organs and pathological lesions (primary prostate lesions and lymph nodes and bone metastases). We evaluated the 68 Ga-PSMA uptake pattern of normal organs, urinary bladder, and pathological lesions. RESULTS: The urinary bladder TAC increased slowly between 180 and 330 s post-injection and then rapidly between 5.5 and 60.0 min post-injection. The pathological lesion uptake increased rapidly during the first 5 min post-injection and then slowly through the remaining 55 min. Six minutes post-injection was the optimal time with the highest pathological lesion SUVmean values still higher than the urinary bladder activity value. However, these prostate lesion, lymph node metastasis, and bone metastasis SUVmean values were one-third, one-half, and one-half the corresponding values 60 min post-injection, suggesting that early imaging might miss low PSMA uptake lesions. A minimum of 35 min post-injection was required for the pathological lesions to have SUVmean values similar to the corresponding values at 60 min post-injection (all P > 0.05), even though the pathological lesion SUVmean values showed a continuous upward trend through the 60 min. CONCLUSIONS: Combining early dynamic 68 Ga-PSMA PET (75-360 s) and conventional static imaging 60 min post-injection could avoid the urinary bladder activity interference to better detect pathological lesions and lesions with relatively low PSMA uptake. The pathological lesion SUVmean values at 35-59 min and 60 min post-injection were similar, so 68 Ga-PSMA PET imaging could also be made at 35-59 min post-injection.
引用
- Wen J, Zhu Y, Li L, et al. Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT. Eur J Nucl Med Mol Imaging. 2021. PMID: 34962583. doi:10.1007/s00259-021-05659-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。